All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| US6837121119 / Opendoor Technologies Inc Warrants expiring 12/18/2025
|
|
|
|
|
|
|
|
| ILMN / Illumina, Inc.
|
|
|
|
|
|
|
|
| HARP / Harpoon Therapeutics, Inc.
|
|
|
|
|
|
|
|
| TILS / TIZIANA LIFE SCIENCES PLC
|
|
|
|
|
|
|
|
| OPTN / OptiNose, Inc.
|
|
|
|
|
|
|
|
| BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| KBNT / Kubient, Inc.
|
|
|
|
|
|
|
|
| AVDL / Avadel Pharmaceuticals plc
|
|
|
|
|
|
|
|
| ITCI / Intra-Cellular Therapies, Inc.
|
|
|
|
|
|
|
|
| LNTH / Lantheus Holdings, Inc.
|
|
|
|
|
|
|
|
| YMTX / Yumanity Therapeutics Inc
|
|
|
|
|
|
|
|
| BLU / Bellus Health Inc
|
|
|
|
|
|
|
|
| CHAQ / Chardan Healthcare Acquisition 2 Corp
|
|
|
|
|
|
|
|
| EPIX / ESSA Pharma Inc.
|
|
|
|
|
|
|
|
| / Cerevel Therapeutics Holdings, Inc. Warrant
|
|
|
|
|
|
|
|
| 15117F138 / Cellectar Biosciences, Inc. Non-Exercisable Warrants
|
|
|
|
|
|
|
|
| / HALL OF FAME RESORT & ENTMT CO WARRANTS EXP 7/15/25 0.00000000
|
|
|
|
|
|
|
|
| PXS / Pyxis Tankers Inc.
|
|
|
|
|
|
|
|
| NMTR / 9 Meters Biopharma Inc
|
|
|
|
|
|
|
|
| CHAQ.WS / Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half (
|
|
|
|
|
|
|
|
| AMHCW / Amplitude Healthcare Acquisition Corp - Warrants (01/12/2026)
|
|
|
|
|
|
|
|
| / Alpha Healthcare Acquisition Corp. Unit
|
|
|
|
|
|
|
|
| HAE / Haemonetics Corporation
|
|
|
|
|
|
|
|
| CBIO / Crescent Biopharma, Inc.
|
|
|
|
|
|
|
|
| ANAB / AnaptysBio, Inc.
|
|
|
|
|
|
|
|
| ICUI / ICU Medical, Inc.
|
|
|
|
|
|
|
|
| US87105M1100 / Switchback Energy Acquisition Corp Warrants
|
|
|
|
|
|
|
|
| EUCR / Eucrates Biomedical Acquisition Corp
|
|
|
|
|
|
|
|
| CRIS / Curis, Inc.
|
|
|
|
|
|
|
|
| QTNT / Quotient Ltd
|
|
|
|
|
|
|
|
| SNDX / Syndax Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| IMUX / Immunic, Inc.
|
|
|
|
|
|
|
|
| DXCM / DexCom, Inc.
|
|
|
|
|
|
|
|
| CNSP / CNS Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| NAUT / Nautilus Biotechnology, Inc.
|
|
|
|
|
|
|
|
| EPZM / Epizyme Inc
|
|
|
|
|
|
|
|
| CHRS / Coherus Oncology, Inc.
|
|
|
|
|
|
|
|
| SCYX / SCYNEXIS, Inc.
|
|
|
|
|
|
|
|
| US7786732021 / Roth Ch Acquisition II Co.
|
|
|
|
|
|
|
|
| TMPMU / Turmeric Acquisition Corp - Units (1 Ord Share Class A & 1/3 War)
|
|
|
|
|
|
|
|
| OCUP / Opus Genetics, Inc.
|
|
|
|
|
|
|
|
| GNPX / Genprex, Inc.
|
|
|
|
|
|
|
|
| OTIC / Otonomy Inc
|
|
|
|
|
|
|
|
| LIFE / aTyr Pharma, Inc.
|
|
|
|
|
|
|
|
| US2103731061 / Constellation Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| VERO / Venus Concept Inc.
|
|
|
|
|
|
|
|
| US92731L1145 / Vincerx Pharma, Inc.
|
|
|
|
|
|
|
|
| GLEO.WS / Galileo Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Ordinary Share
|
|
|
|
|
|
|
|
| TNGX / Tango Therapeutics, Inc.
|
|
|
|
|
|
|
|
| STRO / Sutro Biopharma, Inc.
|
|
|
|
|
|
|
|
| OEG / Orbital Energy Group Inc
|
|
|
|
|
|
|
|
| COGT / Cogent Biosciences, Inc.
|
|
|
|
|
|
|
|
| MICT / M&I Capital Trust B - Preferred Security
|
|
|
|
|
|
|
|
| BLSA / BCLS Acquisition Corp - Class A
|
|
|
|
|
|
|
|
| JYAC / Jiya Acquisition Corp - Class A
|
|
|
|
|
|
|
|
| EIGR / Eiger BioPharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| XENT / Intersect ENT Inc
|
|
|
|
|
|
|
|
| IMTXW / Immatics N.V. - Equity Warrant
|
|
|
|
|
|
|
|
| TVTX / Travere Therapeutics, Inc.
|
|
|
|
|
|
|
|
| TCRR / Tcr2 Therapeutics Inc
|
|
|
|
|
|
|
|
| CSTL / Castle Biosciences, Inc.
|
|
|
|
|
|
|
|
| ARQT / Arcutis Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
| SIEN / Sientra, Inc.
|
|
|
|
|
|
|
|
| KDNY / Chinook Therapeutics Inc
|
|
|
|
|
|
|
|
| VRCA / Verrica Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| SRSAU / Sarissa Capital Acquisition Corp - Units (1 Ord Share Class A & 1/3 War)
|
|
|
|
|
|
|
|
| MYGN / Myriad Genetics, Inc.
|
|
|
|
|
|
|
|
| GMED / Globus Medical, Inc.
|
|
|
|
|
|
|
|
| AGLE / Aeglea BioTherapeutics Inc
|
|
|
|
|
|
|
|
| VINC / Vincerx Pharma, Inc.
|
|
|
|
|
|
|
|
| VSTM / Verastem, Inc.
|
|
|
|
|
|
|
|
| CRNX / Crinetics Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| HSAQ / Health Sciences Acquisitions Corp 2
|
|
|
|
|
|
|
|
| LSAQ / LifeSci Acquisition II Corp
|
|
|
|
|
|
|
|
| ONCT / Oncternal Therapeutics, Inc.
|
|
|
|
|
|
|
|
| IMVT / Immunovant, Inc.
|
|
|
|
|
|
|
|
| CLDX / Celldex Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ISEE / IVERIC bio Inc
|
|
|
|
|
|
|
|
| OCUL / Ocular Therapeutix, Inc.
|
|
|
|
|
|
|
|
| CTIC / CTI BioPharma Corp
|
|
|
|
|
|
|
|
| CRDF / Cardiff Oncology, Inc.
|
|
|
|
|
|
|
|
| PTGX / Protagonist Therapeutics, Inc.
|
|
|
|
|
|
|
|
| PODD / Insulet Corporation
|
|
|
|
|
|
|
|
| HLXA / Helix Acquisition Corp - Class A
|
|
|
|
|
|
|
|
| AUPH / Aurinia Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| GMTX / Gemini Therapeutics Inc
|
|
|
|
|
|
|
|
| SMFR / Sema4 Holdings Corp - Class A
|
|
|
|
|
|
|
|
| SRZN / Surrozen, Inc.
|
|
|
|
|
|
|
|
| INSM / Insmed Incorporated
|
|
|
|
|
|
|
|
| NNDM / Nano Dimension Ltd. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| RIGL / Rigel Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| US30258N1211 / WARRANT
|
|
|
|
|
|
|
|
| LRMR / Larimar Therapeutics, Inc.
|
|
|
|
|
|
|
|
| KPTI / Karyopharm Therapeutics Inc.
|
|
|
|
|
|
|
|
| CLRB / Cellectar Biosciences, Inc.
|
|
|
|
|
|
|
|
| CTMX / CytomX Therapeutics, Inc.
|
|
|
|
|
|
|
|
